SEC Form 4 · accession 0001209191-19-016770
Acer Therapeutics Inc. · ACER
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William T. Andrews
Officer — Chief Medical Officer
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 5:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2019 | A | 9,000 | $0.00 | A | 9,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares issuable upon settlement of a restricted stock unit award that vests in full on March 1, 2020.